CLDN4 and gastric cancer: The overexpression of CLDN4 has been reported in various cancers, including gastric cancer, pancreatic cancer, colorectal cancer, breast cancer, oral squamous cell carcinoma, ovarian cancer, bladder cancer, cholangiocarcinoma, and NSCLC.